Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2710-2721
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2710
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2710
Figure 1 Flow chart of experimental protocol.
φ: Diameter; CA4P: Combretastatin-A4-phosphate; CE: Contrast-enhanced; DCE: Dynamic contrast-enhanced; DENA: Diethylnitrosamine; HCC: Hepatocellular carcinoma; iv: Intravenous(ly); MRI: Magnetic resonance imaging; PBS: Phosphate-buffered saline; R1: R1 rhabdomyosarcoma; T1WI: T1-weighted imaging; T2WI: T2-weighted imaging; WAG/Rij rat: Wistar Albino Glaxo/Rijswijk rat.
- Citation: Liu YW, De Keyzer F, Feng YB, Chen F, Song SL, Swinnen J, Bormans G, Oyen R, Huang G, Ni YC. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers. World J Gastroenterol 2018; 24(25): 2710-2721
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2710.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2710